SEVEN, TEN OR THIRTEEN? THE COST-UTILITY OF INFANT VACCINATION WITH A 7-, 10-OR 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN THE NETHERLANDS

被引：3
|
作者：
Vemer, P. [1 ]
de Greeff, S. C. D. [2 ]
Schouls, L. M. [2 ]
Al, M. J. [1 ]
de Melker, H. D. [2 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
[2] Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)74112-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A228 / A228
页数：1
相关论文
共 50 条
  • [41] Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Compared With 7-valent Pneumococcal Conjugate Vaccine Among Healthy Infants in China
    Zhu, Fengcai
    Hu, Yuemei
    Li, Jingxin
    Ye, Qiang
    Young, Mariano M., Jr.
    Zhou, Xin
    Chen, Zhangjing
    Yan, Bing
    Liang, John Z.
    Gruber, William C.
    Giardina, Peter C.
    Scott, Daniel A.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (09) : 999 - 1010
  • [42] Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada
    Michele Wilson
    Matt Wasserman
    Taj Jadavi
    Maarten Postma
    Marie-Claude Breton
    Francois Peloquin
    Stephanie Earnshaw
    Cheryl McDade
    Heather Sings
    Raymond Farkouh
    Infectious Diseases and Therapy, 2018, 7 : 353 - 371
  • [43] 13-valent Pneumococcal Conjugate Vaccine in Older Children and Adolescents Either Previously Immunized With or Naive to 7-valent Pneumococcal Conjugate Vaccine
    Frenck, Robert, Jr.
    Thompson, Allison
    Senders, Shelly
    Harris-Ford, Laurie
    Sperling, Malcolm
    Patterson, Scott
    Devlin, Carmel
    Jansen, Kathrin U.
    Gruber, William C.
    Emini, Emilio A.
    Scott, Daniel A.
    Gurtman, Alejandra
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (02) : 183 - 189
  • [44] Cost-Effectiveness of the Pneumococcal Conjugate Vaccine (10- or 13-Valent) Versus No Vaccination for a National Immunization Program in Tunisia or Algeria
    Sarah J. Pugh
    Mark A. Fletcher
    Apostolos Charos
    Lynda Imekraz
    Matt Wasserman
    Raymond Farkouh
    Infectious Diseases and Therapy, 2019, 8 : 63 - 74
  • [45] Evaluation of appropriateness of vaccination procedures of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in a hospital setting
    Coleman, Paige
    Sears, Matthew
    Vaichys, Sabina
    Nemecek, Branden
    Guarascio, Anthony
    PHARMACOTHERAPY, 2015, 35 (11): : E305 - E305
  • [46] Direct Comparison of Immunogenicity Induced by 10-or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants
    Wijmenga-Monsuur, Alienke J.
    van Westen, Els
    Knol, Mirjam J.
    Jongerius, Riet M. C.
    Zancolli, Marta
    Goldblatt, David
    van Gageldonk, Pieter G. M.
    Tcherniaeva, Irina
    Berbers, Guy A. M.
    Rots, Nynke Y.
    PLOS ONE, 2015, 10 (12):
  • [47] THE COST-EFFECTIVENESS OF THE NEW PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE (PCV13) FOR CHILDHOOD AND ADULT VACCINATION IN THE UK
    Patel, R.
    Stoykova, B.
    Lloyd, A. C.
    Willingham, J.
    Hollingsworth, R.
    VALUE IN HEALTH, 2009, 12 (07) : A427 - A427
  • [48] Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Among Adults in the Philippines
    Santiaguel, Joel
    Averin, Ahuva
    Nua, Winniefer
    Atwood, Mark
    Huang, Liping
    Hariharan, Dhwani
    Guerrero, Josephine
    Zotomayor, Ricardo
    David-Wang, Aileen
    VALUE IN HEALTH REGIONAL ISSUES, 2025, 47
  • [49] Assessment of Health Benefits and Cost-Effectiveness of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccination in Kenyan Children
    Ayieko, Philip
    Griffiths, Ulla K.
    Ndiritu, Moses
    Moisi, Jennifer
    Mugoya, Isaac K.
    Kamau, Tatu
    English, Mike
    Scott, J. Anthony G.
    PLOS ONE, 2013, 8 (06):
  • [50] Routine infant immunization with the 7- and 13-valent pneumococcal conjugate vaccines: current perspective on reduced-dosage regimens
    Jackowska, Teresa
    Pluta, Justyna
    ARCHIVES OF MEDICAL SCIENCE, 2012, 8 (03) : 542 - 548
12345